139 related articles for article (PubMed ID: 21144359)
1. Familial paraganglioma syndrome: applying genetic screening in otolaryngology.
Dziegielewski PT; Knox A; Liu R; Hung RW; Harris J
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):646-53. PubMed ID: 21144359
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
3. Screening for familial paragangliomas.
Myssiorek D; Ferlito A; Silver CE; Rodrigo JP; Baysal BE; Fagan JJ; Suárez C; Rinaldo A
Oral Oncol; 2008 Jun; 44(6):532-7. PubMed ID: 17936061
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the SDHD gene in a family with inherited paragangliomas--implications of genetic diagnosis for follow up and treatment.
Renard L; Godfraind C; Boon LM; Vikkula M
Head Neck; 2003 Feb; 25(2):146-51. PubMed ID: 12509798
[TBL] [Abstract][Full Text] [Related]
5. Sporadic or familial head neck paragangliomas enrolled in a single center: clinical presentation and genotype/phenotype correlations.
Bacca A; Sellari Franceschini S; Carrara D; Bernini M; Zampa V; Taddei S; Miccoli P; Congregati C; Simi P; Ferrari M; Bernini G
Head Neck; 2013 Jan; 35(1):23-7. PubMed ID: 22290790
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.
Neumann HP; Erlic Z; Boedeker CC; Rybicki LA; Robledo M; Hermsen M; Schiavi F; Falcioni M; Kwok P; Bauters C; Lampe K; Fischer M; Edelman E; Benn DE; Robinson BG; Wiegand S; Rasp G; Stuck BA; Hoffmann MM; Sullivan M; Sevilla MA; Weiss MM; Peczkowska M; Kubaszek A; Pigny P; Ward RL; Learoyd D; Croxson M; Zabolotny D; Yaremchuk S; Draf W; Muresan M; Lorenz RR; Knipping S; Strohm M; Dyckhoff G; Matthias C; Reisch N; Preuss SF; Esser D; Walter MA; Kaftan H; Stöver T; Fottner C; Gorgulla H; Malekpour M; Zarandy MM; Schipper J; Brase C; Glien A; Kühnemund M; Koscielny S; Schwerdtfeger P; Välimäki M; Szyfter W; Finckh U; Zerres K; Cascon A; Opocher G; Ridder GJ; Januszewicz A; Suarez C; Eng C
Cancer Res; 2009 Apr; 69(8):3650-6. PubMed ID: 19351833
[TBL] [Abstract][Full Text] [Related]
7. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
9. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.
Hermsen MA; Sevilla MA; Llorente JL; Weiss MM; Grimbergen A; Allonca E; Garcia-Inclán C; Balbín M; Suárez C
Cell Oncol; 2010 Jan; 32(4):275-83. PubMed ID: 20208144
[TBL] [Abstract][Full Text] [Related]
10. Familial paragangliomas: the emerging impact of molecular genetics on evaluation and management.
Bikhazi PH; Roeder E; Attaie A; Lalwani AK
Am J Otol; 1999 Sep; 20(5):639-43. PubMed ID: 10503587
[TBL] [Abstract][Full Text] [Related]
11. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
12. The genetics of paragangliomas: a review.
Martin TP; Irving RM; Maher ER
Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
[TBL] [Abstract][Full Text] [Related]
13. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
Taschner PE; Bröcker-Vriends AH; van der Mey AG
Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
[TBL] [Abstract][Full Text] [Related]
15. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
16. Malignant head/neck paragangliomas. Comparative study.
Mediouni A; Ammari S; Wassef M; Gimenez-Roqueplo AP; Laredo JD; Duet M; Tran Ba Huy P; Oker N
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):159-66. PubMed ID: 24239180
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
18. Malignant head and neck paragangliomas in SDHB mutation carriers.
Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
[TBL] [Abstract][Full Text] [Related]
19. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
